Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Perrigo Company Public Limited Company
IndexS&P 500 P/E100.10 EPS (ttm)1.55 Insider Own0.10% Shs Outstand133.93M Perf Week6.43%
Market Cap20.78B Forward P/E18.43 EPS next Y8.42 Insider Trans15.53% Shs Float132.87M Perf Month2.91%
Income205.30M PEG7.99 EPS next Q1.44 Inst Own76.60% Short Float1.89% Perf Quarter0.92%
Sales4.06B P/S5.12 EPS this Y-62.00% Inst Trans-0.18% Short Ratio2.80 Perf Half Y5.67%
Book/sh65.02 P/B2.39 EPS next Y13.79% ROA7.60% Target Price170.07 Perf Year20.42%
Cash/sh6.01 P/C25.80 EPS next 5Y12.53% ROE12.70% 52W Range125.18 - 168.14 Perf YTD1.32%
Dividend0.42 P/FCF43.67 EPS past 5Y3.10% ROI2.80% 52W High-7.73% Beta0.34
Dividend %0.27% Quick Ratio1.80 Sales past 5Y15.20% Gross Margin35.70% 52W Low23.94% ATR3.27
Employees10220 Current Ratio2.40 Sales Q/Q18.30% Oper. Margin15.30% RSI (14)62.52 Volatility1.87% 2.25%
OptionableYes Debt/Eq0.37 EPS Q/Q-21.60% Profit Margin22.00% Rel Volume0.52 Prev Close153.91
ShortableYes LT Debt/Eq0.36 EarningsNov 06 BMO Payout4.50% Avg Volume895.05K Price155.15
Recom1.80 SMA203.59% SMA504.44% SMA2004.00% Volume464,514 Change0.81%
22-Sep-14Reiterated RBC Capital Mkts Outperform $160 → $169
15-May-14Reiterated Argus Buy $175 → $160
08-May-14Reiterated B. Riley & Co. Neutral $170 → $157
08-May-14Downgrade RBC Capital Mkts Top Pick → Outperform $187 → $160
03-Mar-14Reiterated UBS Buy $176 → $190
03-Mar-14Reiterated Stifel Buy $165 → $175
25-Feb-14Reiterated CRT Capital Buy $165 → $175
07-Feb-14Downgrade B. Riley & Co. Buy → Neutral
16-Jan-14Reiterated Argus Buy $160 → $175
07-Jan-14Initiated RBC Capital Mkts Top Pick $187
12-Dec-13Reiterated Stifel Buy $150 → $165
07-Nov-13Reiterated Argus Buy $152 → $160
04-Nov-13Reiterated UBS Buy $140 → $160
21-Oct-13Initiated Argus Buy $152
17-Sep-13Initiated CRT Capital Buy $145
30-Jul-13Reiterated B. Riley & Co. Buy $139 → $145
09-Jul-13Reiterated Canaccord Genuity Buy $128 → $140
25-Feb-13Upgrade UBS Neutral → Buy $115 → $130
12-Feb-13Reiterated Deutsche Bank Hold $110 → $115
04-Feb-13Upgrade Canaccord Genuity Hold → Buy $128
23-Oct-14 08:34AM  Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014 PR Newswire
22-Oct-14 10:10AM  Boehringer Ingelheim says not interested in buying Omega Pharma Reuters
20-Oct-14 06:08PM  Actavis, Sanofi among bidders for Omega Pharma - Bloomberg Reuters
05:14PM  Actavis Said to Compete With Sanofi for Omega Pharma Deal at Bloomberg
15-Oct-14 04:33PM  Wife of convicted ex-SAC employee petitions to keep cash, home Reuters
14-Oct-14 10:25AM  Perrigo Animal Health Receives SQF Certification PR Newswire
10-Oct-14 05:37PM  Inversion Vitriol Vs. Drug Consolidation Investor's Business Daily
06-Oct-14 06:08PM  Generics Firms Step Up Their Game In Branded Drugs at Investor's Business Daily
03-Oct-14 06:03PM  U.S. SEC to decide if investors share in $600 mln SAC settlement Reuters
03:45PM  Perrigo Sells Some Assets to Imago Pharmaceuticals Zacks
02-Oct-14 08:48AM  Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 PR Newswire
01-Oct-14 08:53AM  Perrigo Company plc Announces Extension of Exchange Offer for Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 PR Newswire
30-Sep-14 04:10PM  AMAG Up on Roughly $1B deal with Lumara to Widen Portfolio Zacks
29-Sep-14 12:09PM  Akorn Upgraded On Strong Generic Drug Trends at Investor's Business Daily
11:13AM  Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B at TheStreet
08:31AM  Lumara Health to sell assets to AMAG, Perrigo for $757 million at MarketWatch
07:39AM  Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals PR Newswire
07:15AM  Lumara Health to be Acquired in Two Separate Transactions for up to $1.107 Billion PR Newswire
07:08AM  Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health PR Newswire
26-Sep-14 06:07PM  Multiple Sclerosis Drugs Could Transform Market Again at Investor's Business Daily
10-Sep-14 07:38AM  #PreMarket Primer: Wednesday, September 10: Dollar General Gets Aggressive Benzinga
04:17AM  S&P: Inversions Could Lead to Credit Downgrades at The Wall Street Journal
08-Sep-14 06:21PM  SAC's Martoma gets 9 years prison for insider trading Reuters
04:47PM  SAC's Martoma gets 9 years prison for record insider trading scheme Reuters
04-Sep-14 02:01PM  U.S. judge won't toss insider trading conviction of SAC's Martoma Reuters
26-Aug-14 08:25PM  Jim Cramer's 'Mad Money' Recap: A Monster of an August at TheStreet
06:24PM  Despite new highs, Cramer spots a bargain stock at CNBC
22-Aug-14 10:00AM  3 Imperfect Ways To Lower Corporate Taxes And Increase American Jobs at Forbes
14-Aug-14 06:36PM  Perrigo Regains Some Lost Ground On Fiscal Q4 Beat at Investor's Business Daily +7.29%
04:43PM  [video] U.S. Markets Close Higher, Red Robbin Serves Disappointing Earnings at TheStreet
04:37PM  Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving Benzinga
04:25PM  Stocks End With Small Gains; Amgen Shrugs Off Drug Data at Investor's Business Daily
01:15PM  Perrigo Beats on Q4 Earnings and Sales, Provides Guidance Zacks
01:05PM  Cohen, Point72 must face SAC insider trading lawsuit-judge Reuters
11:53AM  Why Perrigo (PRGO) Stock Is Rising Today at TheStreet
11:02AM  Perrigo Q4 Beats Estimates, But Guidance Misses at Investor's Business Daily
10:37AM  Plug Power rallies, GM drops on sell rating at MarketWatch
09:41AM  /C O R R E C T I O N -- Perrigo Company plc/ PR Newswire
07:07AM  Q4 2014 Perrigo Company Earnings Release - Before Market Open CCBN
13-Aug-14 03:49PM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
12-Aug-14 10:06AM  5 Companies That Have Moved Overseas For Lower Taxes Benzinga
10-Aug-14 05:39PM  Benzinga Weekly Preview: US Airstrikes Likely To Wreak Havoc on Markets Benzinga
08-Aug-14 10:25AM  Wall Street Transcript Interview with Howard Zauberman, the President and CEO of Vision-Sciences, Inc. (VSCI) Wall Street Transcript
05-Aug-14 09:00AM  Introducing SENTRY® Petrodex® Advanced Dental Care Calming Kit for Dogs PR Newswire
31-Jul-14 08:58AM  Perrigo Company plc To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014 PR Newswire
30-Jul-14 08:10AM  Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25% PR Newswire
06:12AM  Bob Doll's Best Ideas: Believe In Meg Whitman, Be Wary Of GM at Forbes
28-Jul-14 12:35PM  Bankers push 'tax-dodge' M&A deals Reuters
25-Jul-14 12:48PM  [$$] Three Ways to Play the 'Inversion' Boom at The Wall Street Journal
24-Jul-14 12:56PM  Perrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0% at theflyonthewall.com
12:55PM  Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% PR Newswire
22-Jul-14 07:11AM  #PreMarket Primer: Tuesday, July 22: Separatists Hand Over Remains From Malaysian Airlines Flight Benzinga
21-Jul-14 12:00AM  Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers at Bloomberg
15-Jul-14 12:57PM  Why Perrigo (PRGO) Stock Is Falling Today at TheStreet
12:34PM  Israel Stocks Climb to Three-Week High Amid Perrigo Deal Report at Bloomberg
11:13AM  Perrigo retreats after analyst sees limited potential buyers at theflyonthewall.com
11:05AM  Perilous Reversal Stock: Perrigo (PRGO) at TheStreet
04:23AM  Israel Stocks Head to 3-Week High Amid Perrigo Deal Report at Bloomberg
14-Jul-14 03:01PM  Stocks On Pace For Second Gain; Kandi Keeps Soaring at Investor's Business Daily +8.69%
10:55AM  Trade-Ideas: Perrigo (PRGO) Is Today's "Barbarian At The Gate" Stock at TheStreet
10:38AM  Perrigo move higher attributed to circulation of Globes report at theflyonthewall.com
11-Jul-14 01:03PM  3 Stocks Pulling The Health Care Sector Downward at TheStreet
09-Jul-14 11:14AM  Salix Pharma Stock Falls Despite Tax-Inversion Deal at Investor's Business Daily
08-Jul-14 05:32PM  Ireland: U.S. Tax Inversions Aren't Helping Us Much Either at The Wall Street Journal
08:47AM  Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg PR Newswire
04:39AM  Israeli Stocks Sink to 2-Month Low as Bonds Drop on Gaza Attack at Bloomberg
07-Jul-14 04:58PM  More U.S. companies doing deals to avoid U.S. taxes - Congress study Reuters
23-Jun-14 11:00AM  Perrigo Settles Patent Dispute with Teva Zacks
20-Jun-14 03:19PM  Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does at Seeking Alpha
09:20AM  Perrigo Announces Settlement In Proair® HFA Patent Case PR Newswire
08:00AM  Shocking Prediction: This Little-Known Wal-Mart Supplier Could Double Again StreetAuthority Network
17-Jun-14 01:58PM  [$$] 2 Stocks Riding the Preventive-Care Wave at Barrons.com
16-Jun-14 10:13AM  [video] Medical M&A: Who's next? at CNBC
13-Jun-14 02:00PM  Already Up 438%, This 'Secret' Health Care Giant Could Still Double StreetAuthority Network
11-Jun-14 10:07AM  Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them at Seeking Alpha
06-Jun-14 03:30PM  Alkermes' Pipeline Holds Promise Zacks
01:34PM  Joseph Papa, A Generic CEO With Brand-Name Action at Investor's Business Daily
03-Jun-14 01:03PM  PRGO, VRX And BIIB, Pushing Drugs Industry Downward at TheStreet
30-May-14 08:09AM  Perrigo Company plc To Present At Jefferies 2014 Global Healthcare Conference PR Newswire
06:00AM  Jim Cramer's Top Stock Picks: PLKI MKTO FUEL RUBI PRGO AAPL at TheStreet
29-May-14 08:11PM  Jim Cramer's 'Mad Money' Recap: Which Food Stock Will Be Bought Next? at TheStreet
27-May-14 01:02PM  3 Health Care Stocks Dragging The Sector Down at TheStreet
22-May-14 11:27AM  Catalyst For Perrigo: Sale Of Tysabri Royalties at Seeking Alpha
15-May-14 01:55PM  Perrigo weakness creates buying opportunity, says Argus at theflyonthewall.com
12-May-14 09:25AM  Perrigo announces FDA approval of generic version of Astepro nasal spray at theflyonthewall.com
09:23AM  Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray PR Newswire
11-May-14 05:36AM  Allergan Can Buy Perrigo To Avoid Valeant at Seeking Alpha
08-May-14 09:24AM  Will This Downgrade Hurt Perrigo (PRGO) Stock Today? at TheStreet
08:55AM  Perrigo downgraded to Outperform from Top Pick at RBC Capital at theflyonthewall.com
07:48AM  Perrigo downgraded to Neutral from Buy at Buckingham at theflyonthewall.com
07:19AM  Perrigo downgraded by RBC Capital Mkts Briefing.com
07-May-14 07:02PM  Perrigo missed EPS views Investor's Business Daily -8.70%
04:00PM  Perrigo Public Limited's (PRGO) CEO Joseph Papa on Q3 2014 Results - Earnings Call Transcript at Seeking Alpha
01:15PM  Perrigo Misses on Earnings and Sales, Outlook Slashed Zacks
Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company's Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company's API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Judy LExecutive VP & CFOOct 01Option Exercise48.923,515171,9539,445Oct 02 04:26 PM
Brown Judy LExecutive VP & CFOOct 01Sale150.723,515529,7817,445Oct 02 04:26 PM
Kochan SharonEVP, GM InternationalSep 03Sale150.001,116167,4005,400Sep 04 04:42 PM
KINGMA TODD WExecutive VP, General CounselSep 03Sale150.101,000150,0952,000Sep 03 05:00 PM
Farrington ThomasSenior VP and CIOSep 02Sale150.361,741261,773321Sep 03 05:12 PM
KINGMA TODD WExecutive VP, General CounselAug 29Option Exercise35.851,25044,81310,614Sep 03 05:00 PM
KINGMA TODD WExecutive VP, General CounselAug 29Sale149.301,250186,6259,364Sep 03 05:00 PM
PAPA JOSEPH CPresident and CEODec 12Option Exercise48.5615,000728,401125,506Dec 16 04:30 PM
PAPA JOSEPH CPresident and CEODec 12Sale150.1215,0002,251,819116,655Dec 16 04:30 PM
COHEN GARY MDirectorDec 12Sale152.524,632706,47311,868Dec 16 04:27 PM
JANDERNOA MICHAEL JDirectorDec 09Sale154.9768,62010,634,213120,552Dec 10 03:54 PM
JANDERNOA MICHAEL JDirectorDec 06Sale155.6760,0009,339,918148,000Dec 10 03:54 PM
Yu LouisExecutive VP Global QualityDec 05Sale155.227010,8655,420Dec 09 03:06 PM
Yu LouisExecutive VP Global QualityNov 25Sale155.512,292356,4228,548Nov 26 02:47 PM
KINGMA TODD WExecutive VP, General CounselNov 22Sale154.976,5001,007,3123,000Nov 26 02:48 PM
Brown Judy LExecutive VP & CFONov 21Sale154.749,9881,545,5630Nov 22 02:47 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 20Sale152.808,4001,283,5440Nov 22 02:38 PM
Kochan SharonExecutive VP U.S. GenericsNov 15Sale152.5345569,4015,086Nov 19 02:54 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 12Option Exercise90.654,518409,5572,259Nov 14 02:45 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 12Sale150.004,518677,7000Nov 14 02:45 PM
JANDERNOA MICHAEL JDirectorNov 07Sale144.34755108,973868Nov 12 06:30 PM
Gottfried RanDirectorNov 04Option Exercise89.422,275203,43113,884Nov 06 10:27 AM
Gottfried RanDirectorNov 04Sale143.362,275326,15111,609Nov 06 10:27 AM